The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

Lundbeck’s drug portfolio faces patent expirations but shows growth potential. Find out why HLBBF stock could see upside with ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

The flourishing gray market for intoxicating hemp products like Delta-8 is harming the legal cannabis market while ...

Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...